Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells

Neuropathology

Volumn 34, Issue 2, 2014, Pages 128-134

  Yan, Yong Rong ^a   Xie, Qiang ^a,b   Li, Feng ^b   Zhang, Yong ^a   Ma, Ji Wei ^a   Xie, Si Ming ^a   Li, Hai Ying ^a   Zhong, Xue Yun ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b Department of Gastrointestinal Surgery   (China)

Author keywords

BCNU; Chemotherapy; Drug resistance; EMT; Glioma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARMUSTINE; FIBRONECTIN; GELATINASE B; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; NERVE CELL ADHESION MOLECULE; UVOMORULIN; VIMENTIN; ALKYLATING AGENT; CADHERIN;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METASTASIS POTENTIAL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSEUDOPODIUM; REAL TIME POLYMERASE CHAIN REACTION; SPINDLE CELL; STEM CELL CULTURE; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN NEOPLASMS; DRUG RESISTANCE; GENETICS; GLIOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CADHERINS; CARMUSTINE; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; VIMENTIN;

EID: 84898056927     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12062     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Sarkaria JN, Kitange GJ, James CD etal. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 2008; 14: 2900-2908.
3. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741-4751.
4. Kurrey NK, Jalgaonkar SP, Joglekar AV etal. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009; 27: 2059-2068.
5. Creighton CJ, Li X, Landis M etal. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 2009; 106: 13820-13825.
6. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277-279.
7. Yang AD, Camp ER, Fan F etal. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 2006; 66: 46-51.
8. Miyazono K. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85: 314-323.
9. Yang AD, Fan F, Camp ER etal. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 2006; 12: 4147-4153.
10. Rho JK, Choi YJ, Lee JK etal. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer 2009; 63: 219-226.
11. Wang Z, Li Y, Kong D etal. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 2009; 69: 2400-2407.
12. Xie SM, Fang M, Guo H, Zhong XY. Silencing of MGMT with small interference RNA reversed resistance in human BCUN-resistant glioma cell lines. Chin Med J (Engl) 2011; 124: 2605-2610.
13. Lin C, Liang Y, Zhu H, Zhang J, Zhong X. R280T mutation of p53 gene promotes proliferation of human glioma cells through GSK-3β/PTEN pathway. Neurosci Lett 2012; 529: 60-65.
14. Stupp R, Mason WP, van den Bent MJ etal. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
15. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
16. Cole SP, Bhardwaj G, Gerlach JH etal. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-1654.
17. Mohri M, Nitta H, Yamashita J. Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neurooncol 2000; 49: 105-115.
18. Spiegl-Kreinecker S, Buchroithner J, Elbling L etal. Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. J Neurooncol 2002; 57: 27-36.
19. Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG. The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 2000; 26: 449-462.
20. Kajiyama H, Shibata K, Terauchi M etal. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 2007; 31: 277-283.
21. Hiscox S, Jiang WG, Obermeier K etal. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 2006; 118: 290-301.
22. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 2007; 14: 3629-3637.
23. Zhang W, Feng M, Zheng G etal. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells. Biochem Biophys Res Commun 2012; 417: 679-685.
24. Hoshino H, Miyoshi N, Nagai K etal. Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer. Biochem Biophys Res Commun 2009; 390: 1061-1065.
25. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
26. Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
27. Du Z, Qin R, Wei C etal. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Dig Dis Sci 2011; 56: 741-750.
28. Chen C, Wei Y, Hummel M etal. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011; 6: e16466.
29. Geng S, Guo Y, Wang Q, Li L, Wang J. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Arch Dermatol Res 2013; 305: 35-47.